pioneer 2 semaglutide Efficacy and safety of oral monotherapy vs placebo in a predominantly Chinese population with type diabetes (PIONEER 11): a double-blind, Phase IIIa, randomised trial | Diabetologia pioneer 6 oral semaglutide cardiovascular

RDW ( Supplementary Table 1 ) remained at the initial level for 1 week and reached its maximum on the last day of the trial

"I never was able to get to the weight I needed to be no matter what I did, no matter how much I trained

95% CI [0.550.76]), with a corresponding estimated absolute RR over 3 years of 4.4% and a number needed to treat of 23

Some Medicaid plans provide coverage, but restrictions apply

Baseline characteristics included a mean age of 48 years, 71% female, 72% White, 14% Asian, 9% Black or African American, and 5% reported as other or unknown

doi: 10.1099/vir.0.83328-0 39 KirlyL.KnstlerA.HllerK.FattingerM.JuhszCs.MllerM.et al